isomyosamine
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 11, 2019 (NCT04349761)
Timeline
Indications
Mechanism of action
- TNF-alphaINHIBITOR
TNF inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06942182 | Phase 2 | May 1, 2025 | MyMD Pharmaceuticals, Inc. |
| NCT05283486 | Phase 2 | Feb 1, 2022 | Clinical Research of West Florida, Johns Hopkins University, MyMD Pharmaceuticals, Inc. |
| NCT04349761 | Phase 1 | Jun 11, 2019 | Clinical Research of West Florida, MyMD Pharmaceuticals, Inc., Palm Beach CRO, LLC |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MyMD Pharmaceuticals, Inc. | For profit | 3 | 3 | 2 | 2019 |
| Clinical Research of West Florida | For profit | 2 | 0 | 2 | 2019 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Palm Beach CRO, LLC | For profit | 1 | 0 | 1 | 2019 |
4 organizations
Page 1 / 1